OverviewSuggest Edit
Elekta is a medical device company that manufactures radiotherapy solutions for cancer care and brain disorders. It offers solutions in both radiotherapy treatment and oncology informatics systems for oncology clinics.
| Type | Public | |
| Founded | 1972 | |
| HQ | Stockholm, SE | Map |
| Website | elekta.com | |
| Employee Ratings | More | |
| Overall Culture | B- | More |
Recent NewsAll News
Key People/Management at Elekta
Laurent Leksell
Board Chairman and Chairman of the Compensation and Sustainability Committee
Karin Svenske
Executive Vice President Human Resources
Birgitta Stymne Göransson
Board Member
Maurits Wolleswinkel
Chief Product Officer
John Lapré
President Brachy Solutions
Paul Bergström
Executive Vice President Global Services
Elekta Office Locations
Elekta has offices in Stockholm, Atlanta, North Sydney, Beijing and in 2 other locations
Stockholm, SE (HQ)
Kungstensgatan 18, 103
North Sydney, AU
Suite 10.2, Level 10/146 Arthur St
Beijing, CN
Room 3202 & 3203, Pangu Plaza, Office Building, Block A, No. 27 Fourth Ring Mid Road, Chaoyang District
Veenendaal, NL
Waardgelder 1
Crawley, GB
London Rd
Atlanta, GA, US
400 Perimeter Center Terrace #50
Elekta Financials and Metrics
Elekta Revenue
Elekta's revenue was reported to be kr13.76 b in FY, 2021
| SEK | |
|---|---|
Revenue (Q3, 2022) | 3.6b |
Gross profit (Q3, 2022) | 1.6b |
Net income (Q3, 2022) | 228.0m |
EBITDA (Q3, 2022) | 547.0m |
EBIT (Q3, 2022) | 296.0m |
Market capitalization (13-May-2022) | 27.2b |
Closing stock price (13-May-2022) | 71.3 |
Cash (31-Jan-2022) | 4.4b |
EV | 30.1b |
Elekta's current market capitalization is kr27.2 b.
Annual
| SEK | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|
Revenue | 11.3b | 13.6b | 14.6b | 13.8b |
Cost of goods sold | (6.5b) | (7.8b) | (8.4b) | (8.1b) |
Gross profit | 4.8b | 5.7b | 6.2b | 5.7b |
R&D expense | (671.0m) | (892.0m) | (870.0m) | (764.0m) |
Quarterly
| SEK | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.8b | 3.3b | 3.3b | 3.2b | 3.7b | 3.7b | 3.0b | 3.5b | 3.6b | 3.0b | 3.7b | 3.6b |
Cost of goods sold | (1.5b) | (1.8b) | (1.7b) | (1.5b) | (1.9b) | (2.0b) | (1.3b) | (1.8b) | (1.9b) | (1.6b) | (2.0b) | (2.0b) |
Gross profit | 1.4b | 1.6b | 1.6b | 1.7b | 1.8b | 1.7b | 1.7b | 1.7b | 1.7b | 1.4b | 1.7b | 1.6b |
R&D expense | (365.0m) | (411.0m) | (400.0m) | (431.0m) | (416.0m) | (240.0m) | (386.0m) | (377.0m) | (379.0m) | (390.0m) | (310.0m) | (339.0m) |
Annual
| SEK | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|
Cash | 4.5b | 4.1b | 6.4b | 4.4b |
Accounts Receivable | 3.4b | 3.5b | 3.4b | 3.3b |
Prepaid Expenses | 653.0m | 743.0m | 792.0m | 699.0m |
Inventories | 1.1b | 2.6b | 2.7b | 2.3b |
Quarterly
| SEK | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 3.5b | 3.6b | 2.9b | 3.3b | 3.0b | 2.4b | 5.8b | 3.9b | 4.6b | 3.7b | 2.8b | 4.4b |
Accounts Receivable | 3.1b | 3.0b | 3.8b | 3.6b | 3.5b | 3.9b | 3.2b | 3.2b | 3.3b | 2.9b | 3.0b | 3.7b |
Prepaid Expenses | 160.0m | 178.0m | 169.0m | 111.0m | 191.0m | 172.0m | ||||||
Inventories | 2.5b | 2.5b | 2.5b | 2.8b | 3.0b | 3.0b | 2.5b | 2.5b | 2.4b | 2.5b | 2.4b | 2.7b |
Annual
| SEK | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|
Net Income | 1.4b | 1.6b | 1.5b | 1.6b |
Depreciation and Amortization | 675.0m | 943.0m | 1.3b | 981.0m |
Inventories | (136.0m) | (20.0m) | (116.0m) | 270.0m |
Quarterly
| SEK | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 213.0m | 578.0m | 1.1b | 190.0m | 475.0m | 1.1b | 282.0m | 772.0m | 1.5b | 165.0m | 668.0m | 1.1b |
Depreciation and Amortization | 189.0m | 435.0m | 859.0m | 306.0m | 620.0m | 1.2b | 316.0m | 604.0m | 1.2b | 278.0m | 524.0m | 1.1b |
Inventories | (42.0m) | 30.0m | (32.0m) | (233.0m) | (383.0m) | (512.0m) | 7.0m | 118.0m | 119.0m | (162.0m) | (128.0m) | (430.0m) |
| SEK | FY, 2018 |
|---|---|
Revenue/Employee | 3.1m |
Elekta Revenue Breakdown
Elekta revenue breakdown by business segment: 37.3% from EUROPE, MIDDLE EAST AND AFRICA, 28.2% from NORTH AND SOUTH AMERICA and 34.4% from ASIA PACIFIC
Elekta Cybersecurity Score
Elekta Environment, Social & Governance (ESG) Ratings
Elekta Online and Social Media Presence
11.56k Twitter followers
Elekta has 11.56k Twitter Followers. The number of followers has increased 0.6% month over month and increased 1.7% quarter over quarter
Elekta's Trends
Twitter Engagement Stats for @Elekta
10.8k
Tweets
4.5k
Following
11.6k
Followers
40
Tweets last 30 days
6.2
Avg. likes per Tweet
97.5%
Tweets with engagement
Elekta Company Culture
Overall Culture
B-
70/100
CEO Rating
B
73/100
Compensation
A-
78/100
Diversity
C
67/100
Elekta News and Updates
January 07, 2022
Elekta to appoint Tobias Hägglöv as Chief Financial Officer
STOCKHOLM, Jan. 7, 2022 /PRNewswire/ -- Elekta (STO: EKTA-B) announced today that it will appoint Tobias Hägglöv as Chief Financial Officer effective February 1, 2022, taking over from Johan Adebäck. Tobias Hägglöv has previously held the role of CFO at Recipharm as well as senior...
November 25, 2021
More cancer patients in Africa to benefit from advanced radiation therapy with Elekta Unity MR-Linac
STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCESS 2025 strategy, which includes giving more than 300 million people access to radiation...
October 29, 2021
Elekta establishes a framework for sustainability-linked bonds
STOCKHOLM, Oct. 29, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has established a Sustainability-Linked Bond Framework (SLB Framework) for issues of sustainability-linked bonds under its Medium Term Note Program (MTN-Program). Elekta is among the first companies in...
September 02, 2021
Elekta acquires Turkish distributor to strengthen market position
STOCKHOLM, Sept. 2, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has acquired its long-time partner and Turkish distributor of neurosurgery solutions, Özyürek Mümessillik ve Dış Ticaret A.Ş. (Özyürek A.Ş.). The acquisition will improve Elekta's market access in the...
August 31, 2021
Elekta Unity MR-Linac featured in 72 abstracts at European radiation oncology congress
MADRID, August 31, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of 72 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Unity MR-Linac. The research described in the abstracts was conducted at 14 leading cancer centers...
August 26, 2021
Elekta's Board announces establishment of philanthropic Elekta Foundation
STOCKHOLM, Aug. 26, 2021 /PRNewswire/ -- At its Annual General Meeting on August 25, Elekta's (EKTA-B.ST) shareholders approved the Board of Directors' proposal to establish the Elekta Foundation. The Elekta Foundation's mission is an important part of Elekta's environmental, social, and...
Elekta Blogs
February 24, 2022
Interim report, May–January 2021/22
February 14, 2022
Elekta announces preliminary third quarter results
November 25, 2021
Interim report, May–October 2021/22
The increasing need for investments in cancer care and radiotherapy across the globe supported a gradual market recovery during the quarter. Our orders grew with double digits, and despite the continued global supply chain challenges we secured good revenue growth supported by a strong finish of the…
November 04, 2021
Invitation to the presentation of Elekta's second quarter 2021/22
Elekta Frequently Asked Questions
When was Elekta founded?
Elekta was founded in 1972.
Who are Elekta key executives?
Elekta's key executives are Laurent Leksell, Karin Svenske and Birgitta Stymne Göransson.
How many employees does Elekta have?
Elekta has 4,175 employees.
What is Elekta revenue?
Latest Elekta annual revenue is kr13.8 b.
What is Elekta revenue per employee?
Latest Elekta revenue per employee is kr3.3 m.
Who are Elekta competitors?
Competitors of Elekta include ViewRay, Accuray and Flatiron Health.
Where is Elekta headquarters?
Elekta headquarters is located at Kungstensgatan 18, 103, Stockholm.
Where are Elekta offices?
Elekta has offices in Stockholm, Atlanta, North Sydney, Beijing and in 2 other locations.
How many offices does Elekta have?
Elekta has 6 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies